Table 2.
Baseline clinical and laboratory data on admission in the study groups (significant differences in bold)
| Variables | Anemia (n = 37) |
Non-anemia (n = 37) |
P value |
|---|---|---|---|
| Age (months) | 6.18 ±4.20 | 6.42 ±3.02 | 0.776 |
| Female (%) | 19 (51.3) | 21 (56.7) | 0.605 |
| Fever presence (%) | 32 (86.5) | 25 (67.6) | 0.066 |
| Fever duration (days) | 3.03 ±1.83 | 1.81 ±1.70 | 0.004 |
| CAKUT (%) | 7 (18.9) | 7 (18.9) | 1.00 |
| Creatinine (mg/dl) | 0.27 ±0.07 | 0.28 ±0.09 | 0.473 |
| NGAL (ng/ml) | 143.54 ±72.00 | 113.80 ±75.28 | 0.087 |
| WBC (× 103/µl) | 18.59 ±6.65 | 18.12 ±5.90 | 0.749 |
| Neutrophils (%) | 48.58 ±16.68 | 44.89 ±19.59 | 0.386 |
| CRP (mg/dl) | 7.00 (2.80; 14.90) | 3.40 (1.70; 6.60 | 0.005 |
| PCT (ng/ml) | 0.73 (0.11; 2.05) | 0.13 (0.06; 0.49) | 0.015 |
CAKUT – congenital anomalies of the kidney and urinary tract, NGAL – neutrophil gelatinase-associated lipocalin, WBC – white blood cells, CRP – C-reactive protein, PCT – procalcitonin